INNOVATE Corp. reports developments across a diversified portfolio organized around Infrastructure, Life Sciences and Spectrum. News commonly covers consolidated earnings, subsidiary performance, DBM Global cash dividends, steel construction activity, Spectrum network and broadcasting updates, and capital or operating developments within portfolio companies.
Life Sciences updates center on MediBeacon, an equity method investment developing fluorescent tracer agents and transdermal detection for kidney function assessment through the TGFR System, including FDA, NMPA and CE Mark regulatory milestones. INNOVATE also reports R2 system sales and commercial agreements as part of its portfolio-company operating updates.
INNOVATE (VATE) completed the sale of its approximately 91.21% stake in DBM Global to IES Holdings (IESC).
IES acquired all outstanding DBM Global common shares. INNOVATE and DBM Global Intermediate Holdco, together the Seller, received approximately $378 million in cash and 430,974 IES shares, valued at approximately $146 million using the October 2, 2026 closing price. A further $35 million cash payment compensated Seller for costs and obligations connected with a joint tax election, bringing total closing cash to approximately $413 million.
The purchase price remains subject to post-closing finalization. The IES shares carry a maximum 60-day lock-up following closing, subject to agreement terms. INNOVATE intends to use all net transaction proceeds to reduce outstanding debt.
IES Holdings (NASDAQ: IESC) completed its acquisition of DBM Global for approximately $691 million in cash and IES common stock. IES acquired 100% of DBM Global’s common stock, including INNOVATE’s approximately 91.2% interest and the remaining stockholders’ interests. DBM Global became IES’s new Structural line of business on October 5, 2026.
Consideration comprised approximately $545 million in cash and 430,974 IES shares valued at approximately $146 million using the October 2, 2026 closing price, subject to customary post-closing adjustments. Cash on hand and borrowings under an amended and expanded Wells Fargo-arranged credit facility funded the cash payment. DBM Global generated approximately $1.5 billion in revenue for the twelve months ended June 30, 2026. IES expects cash flow from both businesses to support rapid repayment of acquisition-related borrowings.
INNOVATE (VATE) has closed the sale of a controlling interest in its Broadcasting segment holding company, HC2 Broadcasting Holdings, to CONX Corp., following a refinancing completed on June 1, 2026.
CONX now holds a 75% ownership interest in HC2, while INNOVATE retains 25%, subject to potential reduction due to post-closing purchase price adjustments and certain expense and indemnification obligations. As part of the transaction, CONX committed to fund up to $75 million of equity into HC2, a portion at closing and the remainder after closing, also subject to potential reduction. The previously announced $105 million loan entered in connection with the refinancing, together with accrued interest, was extinguished in accordance with the transaction agreements, which the company says strengthens its balance sheet and capital structure. For 18 months after closing, INNOVATE may buy up to an additional 15% ownership interest in HC2 from CONX, while for two years from May 29, 2026, a CONX affiliate holds an option to increase its HC2 stake up to 80.1%.
INNOVATE (NYSE: VATE) reported that its equity method investment MediBeacon has had its MediBeacon® TGFR™ System nominated by The Galien Foundation for the 2026 Prix Galien USA Best Medical Technology. The first-in-kind, point-of-care system assesses kidney function transdermally, with winners to be announced on October 29, 2026, in New York City.
IES Holdings (NASDAQ: IESC) has entered into a definitive agreement to acquire DBM Global, a vertically integrated structural steel fabrication, erection and industrial services platform, from INNOVATE Corp (NYSE: VATE). The consideration for DBM Global, including minority interests, is approximately $650 million, payable in cash and shares of IES common stock.
DBM Global generated about $1.3 billion in revenue in the twelve months ended March 31, 2026, employs roughly 3,400 people and operates over 2 million square feet of facilities across the U.S. Upon closing, expected in the quarter ending December 31, 2026 subject to customary conditions and regulatory approvals, DBM Global will form a new Structural line of business within IES, expanding its capabilities across commercial, industrial, data center, stadium and infrastructure markets.
INNOVATE (NYSE: VATE) agreed to sell its approximately 91.21% stake in DBM Global (DBMG) to IES Holdings (Nasdaq: IESC), as part of a 100% acquisition of DBMG valued at an aggregate base purchase price of $650 million, subject to customary adjustments.
According to INNOVATE, consideration to INNOVATE and DBM Global Intermediate Holdco will include their pro rata share of $510 million cash (approximately $453 million after giving effect to their receipt of all IES stock), plus 215,487 IES shares valued at $140 million at signing, and an additional $35 million cash at closing related to a joint tax election. Other DBMG stockholders holding about 8.79% will receive all-cash consideration. INNOVATE intends to use all net proceeds to reduce outstanding debt. The transaction has board approval and is expected to close in the quarter ending December 31, 2026, subject to regulatory and other customary closing conditions.
INNOVATE Corp. (NYSE: VATE) reported second quarter 2026 consolidated revenue of $421.6 million, up 74.2% year over year, driven mainly by Infrastructure subsidiary DBM Global (DBMG). Net income attributable to common and participating preferred stockholders was $10.4 million, versus a loss of $22.0 million, and diluted EPS was $0.71, compared with a loss of $1.67. Total Adjusted EBITDA rose to $46.3 million from $15.7 million.
DBMG generated revenue of $414.0 million (up 77.6%), net income of $26.4 million and Adjusted EBITDA of $48.7 million, with Adjusted EBITDA margin of 11.8% and record adjusted backlog of $2.7 billion. Life Sciences revenue was $2.2 million (down from $3.2 million), while Spectrum (Broadcasting) revenue was $5.4 million (slightly below $5.7 million) but segment net income improved to $8.4 million from a $6.1 million loss.
Broadcasting closed a $105 million refinancing and INNOVATE agreed to sell a controlling interest in Broadcasting to CONX CORP., after which CONX is expected to own ~75% and INNOVATE ~25%. INNOVATE is also pursuing substantial asset dispositions, including a sales process for DBMG and a majority interest in Broadcasting, alongside broader debt and liability changes.
INNOVATE Corp. (NYSE: VATE) will release its second quarter 2026 financial results on Thursday, August 6, 2026, after market close. On the same day, the company will host an earnings conference call at 4:30 p.m. ET to review results, operations and strategy.
The live call can be accessed via domestic dial-in 1-877-704-4453 or international 1-201-389-0920, and will also be webcast through the Investor Relations section of INNOVATE’s website. A replay will be available by phone and online, with telephone replay access through August 20, 2026 using conference number 13761666.
INNOVATE (NYSE:VATE) announced that its operating subsidiary DBM Global will pay a cash dividend of about $12 million, or $3.12 per share, on August 3, 2026 to DBMG stockholders of record on July 20, 2026. INNOVATE, as the largest DBMG stockholder, expects to receive about $11 million. INNOVATE’s public stockholders will not receive this dividend.
INNOVATE (NYSE: VATE) announced a refinancing for HC2 Broadcasting and a definitive agreement to sell a controlling stake in Broadcasting to CONX CORP, subject to regulatory approvals.
CONX is expected to own about 75% of Broadcasting post-closing, with INNOVATE retaining about 25%, plus options and an equity commitment structure totaling up to $180 million.